Registration Dossier

Diss Factsheets

Administrative data

Description of key information

Data on the substance Donepezil hydrochloride CAS 120014-06-4

Key value for chemical safety assessment

Justification for classification or non-classification

Additional information

No evidence of a carcinogenic potential was obtained in an 88-week carcinogenicity study of donepezil hydrochloride conducted in CD-1 mice at doses up to 180 mg/kg/day (approximately 90 times the maximum recommended human dose on a mg/m2 basis), or in a 104-week carcinogenicity study in Sprague-Dawley rats at doses up to 30mg/kg/day (approximately 30 times the maximum recommended human dose on a mg/m2 basis).